Association of Epigenetic Markers of Aging With Prevalent and Incident Type 2 Diabetes
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2025
DOI: 10.1093/gerona/glaf085 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2025. Verfasst von Danmeng Lily Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Aging, Epigenesis, Genetic, DNA Methylation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Melbourne Collaborative Cohort Study, Wellcome Trust, National Health and Medical Research Council.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes (T2D) is characterized by elevated levels of metabolic and inflammatory markers but less is known about other molecular alterations that occur with aging. We aimed to assess the associations of DNA methylation-based measures of aging (epigenetic aging) with prevalent and incident T2D in a large sample of middle-aged and older Australians.
Methods
We used data from 5 403 participants in the Melbourne Collaborative Cohort Study (mean age = 59 years). Five blood-based epigenetic aging measures: PCPhenoAge, PCGrimAge, DNAmFitAge, bAge, and DunedinPACE were calculated. T2D status was assessed at baseline (1990–1994, Ncases = 180) and 2 waves of follow-up (1995–1998, Ncases = 134; 2003–2007, Ncases = 244). Modified Poisson regression models were used to estimate risk ratios for the associations of epigenetic age with prevalent and incident T2D.
Results
A standard deviation increase in epigenetic age was associated with 1.11-fold (PCPhenoAge, 95%CI: 0.98–1.26) to 1.33-fold (bAge, 95%CI: 1.12–1.57) higher prevalence of T2D at baseline. Prospectively, DunedinPACE showed the strongest association with incident T2D at follow-up 2 (risk ratio = 1.22, 95%CI: 1.07–1.38). These estimates were slightly attenuated but consistent in sensitivity analyses reclassifying participants who reported being T2D-free but had high glucose concentrations (> 7 mmol/L for fasting glucose, > 11.1 mmol/L for nonfasting glucose). No evidence of increased epigenetic age was found for participants with pre-T2D (> 5.6 mmol/L for fasting glucose, > 7.8 mmol/L for nonfasting glucose). The positive associations between epigenetic age and fasting glucose levels appeared stronger in participants with T2D.
Conclusions
In middle-aged and older Australians, epigenetic age, in particular as assessed by bAge and DunedinPACE, was positively associated with prevalent and incident T2D. Our findings may have implications for understanding the etiology and management of T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
- Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
- Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.
ORCID-Profile: Pierre-Antoine Dugué
Förderung
- Melbourne Collaborative Cohort Study
- Wellcome Trust
- National Health and Medical Research Council
Zitieren
APA
Li, D. L., Hodge, A. M., Southey, M. C., Giles, G. G., & Dugué, P. A. (2025). Association of Epigenetic Markers of Aging With Prevalent and Incident Type 2 Diabetes. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glaf085
Vancouver
Li DL, Hodge AM, Southey MC, Giles GG, Dugué PA. Association of Epigenetic Markers of Aging With Prevalent and Incident Type 2 Diabetes. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025. doi:10.1093/gerona/glaf085
BibTeX
@article{Li2025,
author = {Li, Danmeng Lily and Hodge, Allison M and Southey, Melissa C and Giles, Graham G and Dugué, Pierre-Antoine},
title = {Association of Epigenetic Markers of Aging With Prevalent and Incident Type 2 Diabetes},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2025},
doi = {10.1093/gerona/glaf085}
}
EUVIMED